. 2021 Dec 16;12:764331. doi: 10.3389/fphar.2021.764331
Copyright © 2021 Yang, Wu, Dai, Pang, Xie, Ren, Zhang, Bi, Zheng, Wang, Sun, Zheng and Kong.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
FIGURE 2.
Diseases involved in the current study of the antitumor potential of tetramethylpyrazine.